In February 2021, we started cooperation with DG-Nika AG from Switzerland on the implementation of a research project aimed at developing and market launch of a drug that blocks the proliferation of the SARS-Cov-2 coronavirus that causes the COVID-19 disease.
The main tasks and role of the SORBOLAB Research Laboratory in this interesting project is the preparation and evaluation of histologic preparations from tissues and organs taken during in vivo toxicological tests, performed for the purpose of the toxicological evaluation of the product.
We are happy to be part of a team whose work will contribute to the effective fight against the coronavirus pandemic.
More information can be found at: https://dg-nika.net